Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
OTC Drug and Dietary Supplement market report explains the definition, types, applications, major countries, and major players of the OTC Drug and Dietary Supplement market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Suntory
GSK
Herbalife
Pfizer
Amway
Bayer
Abbott
Blackmores
Glanbia
Reckitt Benckiser
By Type:
Tablets
Powders
Capsules
Liquids
By End-User:
Convenience Stores
Pharmacies
Supermarkets
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global OTC Drug and Dietary Supplement Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 OTC Drug and Dietary Supplement Outlook to 2028- Original Forecasts
-
2.2 OTC Drug and Dietary Supplement Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term OTC Drug and Dietary Supplement Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global OTC Drug and Dietary Supplement Market- Recent Developments
-
6.1 OTC Drug and Dietary Supplement Market News and Developments
-
6.2 OTC Drug and Dietary Supplement Market Deals Landscape
7 OTC Drug and Dietary Supplement Raw Materials and Cost Structure Analysis
-
7.1 OTC Drug and Dietary Supplement Key Raw Materials
-
7.2 OTC Drug and Dietary Supplement Price Trend of Key Raw Materials
-
7.3 OTC Drug and Dietary Supplement Key Suppliers of Raw Materials
-
7.4 OTC Drug and Dietary Supplement Market Concentration Rate of Raw Materials
-
7.5 OTC Drug and Dietary Supplement Cost Structure Analysis
-
7.5.1 OTC Drug and Dietary Supplement Raw Materials Analysis
-
7.5.2 OTC Drug and Dietary Supplement Labor Cost Analysis
-
7.5.3 OTC Drug and Dietary Supplement Manufacturing Expenses Analysis
8 Global OTC Drug and Dietary Supplement Import and Export Analysis (Top 10 Countries)
-
8.1 Global OTC Drug and Dietary Supplement Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global OTC Drug and Dietary Supplement Export by Region (Top 10 Countries) (2017-2028)
9 Global OTC Drug and Dietary Supplement Market Outlook by Types and Applications to 2022
-
9.1 Global OTC Drug and Dietary Supplement Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Powders Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Capsules Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Liquids Consumption and Growth Rate (2017-2022)
-
9.2 Global OTC Drug and Dietary Supplement Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Convenience Stores Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Supermarkets Consumption and Growth Rate (2017-2022)
10 Region and Country-wise OTC Drug and Dietary Supplement Market Analysis and Outlook till 2022
-
10.1 Global OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.2.2 Canada OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.2.3 Mexico OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.2 UK OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.3 Spain OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.4 Belgium OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.5 France OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.6 Italy OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.7 Denmark OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.8 Finland OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.9 Norway OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.10 Sweden OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.11 Poland OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.12 Russia OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.3.13 Turkey OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.2 Japan OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.3 India OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.4 South Korea OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.5 Pakistan OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.6 Bangladesh OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.7 Indonesia OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.8 Thailand OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.9 Singapore OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.10 Malaysia OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.11 Philippines OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.4.12 Vietnam OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.5.2 Colombia OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.5.3 Chile OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.5.4 Argentina OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.5.5 Venezuela OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.5.6 Peru OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.5.7 Puerto Rico OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.5.8 Ecuador OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.6.2 Kuwait OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.6.3 Oman OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.6.4 Qatar OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.6.5 Saudi Arabia OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.6.6 United Arab Emirates OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.7.2 South Africa OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.7.3 Egypt OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.7.4 Algeria OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia OTC Drug and Dietary Supplement Consumption (2017-2022)
-
10.8.2 New Zealand OTC Drug and Dietary Supplement Consumption (2017-2022)
11 Global OTC Drug and Dietary Supplement Competitive Analysis
-
11.1 Suntory
-
11.1.1 Suntory Company Details
-
11.1.2 Suntory OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Suntory OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.1.4 Suntory OTC Drug and Dietary Supplement Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 GSK
-
11.2.1 GSK Company Details
-
11.2.2 GSK OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 GSK OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.2.4 GSK OTC Drug and Dietary Supplement Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Herbalife
-
11.3.1 Herbalife Company Details
-
11.3.2 Herbalife OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Herbalife OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.3.4 Herbalife OTC Drug and Dietary Supplement Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Pfizer
-
11.4.1 Pfizer Company Details
-
11.4.2 Pfizer OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Pfizer OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.4.4 Pfizer OTC Drug and Dietary Supplement Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Amway
-
11.5.1 Amway Company Details
-
11.5.2 Amway OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Amway OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.5.4 Amway OTC Drug and Dietary Supplement Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bayer
-
11.6.1 Bayer Company Details
-
11.6.2 Bayer OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bayer OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.6.4 Bayer OTC Drug and Dietary Supplement Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Abbott
-
11.7.1 Abbott Company Details
-
11.7.2 Abbott OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Abbott OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.7.4 Abbott OTC Drug and Dietary Supplement Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Blackmores
-
11.8.1 Blackmores Company Details
-
11.8.2 Blackmores OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Blackmores OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.8.4 Blackmores OTC Drug and Dietary Supplement Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Glanbia
-
11.9.1 Glanbia Company Details
-
11.9.2 Glanbia OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Glanbia OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.9.4 Glanbia OTC Drug and Dietary Supplement Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Reckitt Benckiser
-
11.10.1 Reckitt Benckiser Company Details
-
11.10.2 Reckitt Benckiser OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Reckitt Benckiser OTC Drug and Dietary Supplement Main Business and Markets Served
-
11.10.4 Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global OTC Drug and Dietary Supplement Market Outlook by Types and Applications to 2028
-
12.1 Global OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Powders Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Capsules Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Liquids Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Convenience Stores Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Supermarkets Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise OTC Drug and Dietary Supplement Market Analysis and Outlook to 2028
-
13.1 Global OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.2.2 Canada OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.2.3 Mexico OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.2 UK OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.3 Spain OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.4 Belgium OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.5 France OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.6 Italy OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.7 Denmark OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.8 Finland OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.9 Norway OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.10 Sweden OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.11 Poland OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.12 Russia OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.3.13 Turkey OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.2 Japan OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.3 India OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.4 South Korea OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.5 Pakistan OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.7 Indonesia OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.8 Thailand OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.9 Singapore OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.10 Malaysia OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.11 Philippines OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.4.12 Vietnam OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.5.2 Colombia OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.5.3 Chile OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.5.4 Argentina OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.5.5 Venezuela OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.5.6 Peru OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.5.8 Ecuador OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.6.2 Kuwait OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.6.3 Oman OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.6.4 Qatar OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.7.2 South Africa OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.7.3 Egypt OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.7.4 Algeria OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
-
13.8.2 New Zealand OTC Drug and Dietary Supplement Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of OTC Drug and Dietary Supplement
-
Figure of OTC Drug and Dietary Supplement Picture
-
Table Global OTC Drug and Dietary Supplement Import by Region (Top 10 Countries) (2017-2028)
-
Table Global OTC Drug and Dietary Supplement Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Powders Consumption and Growth Rate (2017-2022)
-
Figure Global Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global Liquids Consumption and Growth Rate (2017-2022)
-
Figure Global Convenience Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Supermarkets Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Drug and Dietary Supplement Consumption by Country (2017-2022)
-
Table North America OTC Drug and Dietary Supplement Consumption by Country (2017-2022)
-
Figure United States OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Canada OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Mexico OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Table Europe OTC Drug and Dietary Supplement Consumption by Country (2017-2022)
-
Figure Germany OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure UK OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Spain OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Belgium OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure France OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Italy OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Denmark OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Finland OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Norway OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Sweden OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Poland OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Russia OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Turkey OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Table APAC OTC Drug and Dietary Supplement Consumption by Country (2017-2022)
-
Figure China OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Japan OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure India OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure South Korea OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Pakistan OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Indonesia OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Thailand OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Singapore OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Malaysia OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Philippines OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Vietnam OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Table South America OTC Drug and Dietary Supplement Consumption by Country (2017-2022)
-
Figure Brazil OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Colombia OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Chile OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Argentina OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Venezuela OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Peru OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Ecuador OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Table GCC OTC Drug and Dietary Supplement Consumption by Country (2017-2022)
-
Figure Bahrain OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Kuwait OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Oman OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Qatar OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Table Africa OTC Drug and Dietary Supplement Consumption by Country (2017-2022)
-
Figure Nigeria OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure South Africa OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Egypt OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure Algeria OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Table Oceania OTC Drug and Dietary Supplement Consumption by Country (2017-2022)
-
Figure Australia OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Figure New Zealand OTC Drug and Dietary Supplement Consumption and Growth Rate (2017-2022)
-
Table Suntory Company Details
-
Table Suntory OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Suntory OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Suntory OTC Drug and Dietary Supplement Product Portfolio
-
Table GSK Company Details
-
Table GSK OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table GSK OTC Drug and Dietary Supplement Product Portfolio
-
Table Herbalife Company Details
-
Table Herbalife OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Herbalife OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Herbalife OTC Drug and Dietary Supplement Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Pfizer OTC Drug and Dietary Supplement Product Portfolio
-
Table Amway Company Details
-
Table Amway OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amway OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Amway OTC Drug and Dietary Supplement Product Portfolio
-
Table Bayer Company Details
-
Table Bayer OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Bayer OTC Drug and Dietary Supplement Product Portfolio
-
Table Abbott Company Details
-
Table Abbott OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Abbott OTC Drug and Dietary Supplement Product Portfolio
-
Table Blackmores Company Details
-
Table Blackmores OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Blackmores OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Blackmores OTC Drug and Dietary Supplement Product Portfolio
-
Table Glanbia Company Details
-
Table Glanbia OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glanbia OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Glanbia OTC Drug and Dietary Supplement Product Portfolio
-
Table Reckitt Benckiser Company Details
-
Table Reckitt Benckiser OTC Drug and Dietary Supplement Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reckitt Benckiser OTC Drug and Dietary Supplement Main Business and Markets Served
-
Table Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Powders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liquids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Convenience Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Supermarkets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Drug and Dietary Supplement Consumption Forecast by Country (2022-2028)
-
Table North America OTC Drug and Dietary Supplement Consumption Forecast by Country (2022-2028)
-
Figure United States OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe OTC Drug and Dietary Supplement Consumption Forecast by Country (2022-2028)
-
Figure Germany OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure France OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC OTC Drug and Dietary Supplement Consumption Forecast by Country (2022-2028)
-
Figure China OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure India OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Table South America OTC Drug and Dietary Supplement Consumption Forecast by Country (2022-2028)
-
Figure Brazil OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC OTC Drug and Dietary Supplement Consumption Forecast by Country (2022-2028)
-
Figure Bahrain OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa OTC Drug and Dietary Supplement Consumption Forecast by Country (2022-2028)
-
Figure Nigeria OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania OTC Drug and Dietary Supplement Consumption Forecast by Country (2022-2028)
-
Figure Australia OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand OTC Drug and Dietary Supplement Consumption Forecast and Growth Rate (2022-2028)
-
